DMD Advocates represented HBM Healthcare Investments and other investors in leading an INR8.5 billion (USD97.7 million) pre-listing funding round for OneSource Specialty Pharma.
Partner Ayesha Rai led the DMD team, with the support of principal associate Pooja Shah and associate Vanshikha Choraria. Partner Vihang Virkar acted as the engagement partner on the matter.
DSK Legal acted for OneSource Specialty Pharma, formerly known as Stelis Biopharma.
HBM Healthcare Investments is a Swiss company with a diversified investment portfolio in the private and public healthcare enterprises.
OneSource, a contract development and manufacturing organisation and an associate company of Strides Pharma, plans to debut shortly. OneSource completed a demerger from its parent company Strides Pharma in December 2024.
The capital raised will be invested in research and development initiatives, expanding its product portfolio and market position in preparation for its initial public offering.
